Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Acute Inflammatory Demyelinating Polyradiculoneuropathy. Data from NIH RePORTER, last 36 months.
Acute Inflammatory Demyelinating Polyradiculoneuropathy has active NIH research funding with 8 funded grants totaling $6.7M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Acute Inflammatory Demyelinating Polyradiculoneuropathy. Strongest funded area: Basic Science. Largest gap: Translational / Drug Development.
2 funded grants in Translational / Drug Development but only 0 related publications found for acute inflammatory demyelinating polyradiculoneuropathy. This may indicate early-stage research that hasn't yet produced published results.
3 funded grants in Basic Science but only 2 related publications found for acute inflammatory demyelinating polyradiculoneuropathy. This may indicate early-stage research that hasn't yet produced published results.
These grants mention Acute Inflammatory Demyelinating Polyradiculoneuropathy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.